Works matching IS 10781552 AND DT 2023 AND VI 29 AND IP 2
Results: 38
Alpelisib induced interstitial lung disease in a patient with advanced breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 484, doi. 10.1177/10781552221107532
- By:
- Publication type:
- Article
VicTAG chemotherapy audit toolkit: Improving chemotherapy quality and safety.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 416, doi. 10.1177/10781552221148118
- By:
- Publication type:
- Article
Administration of ciprofloxacin through a nasogastric tube in pediatric oncology and stem cell transplantation patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 413, doi. 10.1177/10781552221147891
- By:
- Publication type:
- Article
An overview of the role of selpercatinib and pralsetinib in RET-fusion-positive non-small cell lung cancer (NSCLC).
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 450, doi. 10.1177/10781552221147500
- By:
- Publication type:
- Article
A review of the novel tissue factor antibody–drug conjugate: Tisotumab vedotin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 441, doi. 10.1177/10781552221139775
- By:
- Publication type:
- Article
Cost-effectiveness of poly-(ADP-ribose) polymerase (PARP)-inhibitors for the maintenance treatment after responding to first- and second-line chemotherapy in advanced ovarian cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 457, doi. 10.1177/10781552221137705
- By:
- Publication type:
- Article
Pharmacokinetic characterization, benefits and barriers of subcutaneous administration of monoclonal antibodies in oncology.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 431, doi. 10.1177/10781552221137702
- By:
- Publication type:
- Article
Safe handling of hazardous drugs.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 401, doi. 10.1177/10781552221135121
- By:
- Publication type:
- Article
KRAS-targeted therapy in the treatment of non-small cell lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 422, doi. 10.1177/10781552221118848
- By:
- Publication type:
- Article
Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 511, doi. 10.1177/10781552221114070
- By:
- Publication type:
- Article
High-dose methotrexate-related pneumonitis in a child with acute lymphoblastic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 506, doi. 10.1177/10781552221112160
- By:
- Publication type:
- Article
Asymptomatic unilateral phrenic nerve palsy after bortezomib treatment in a newly diagnosed multiple myeloma patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 502, doi. 10.1177/10781552221112151
- By:
- Publication type:
- Article
A case of castration-resistant metastatic prostate cancer who continued treatment with enzalutamide after epileptic seizure.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 498, doi. 10.1177/10781552221112018
- By:
- Publication type:
- Article
Orbital myeloid sarcoma treated with low-dose venetoclax and a potent cytochrome P450 inhibitor.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 493, doi. 10.1177/10781552221110826
- By:
- Publication type:
- Article
Tamoxifen induced maculopathy presenting like macular telangiectasia type 2 in a patient with breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 489, doi. 10.1177/10781552221110472
- By:
- Publication type:
- Article
Nivolumab-induced pneumonitis and cardiopathy in a patient with relapsed Hodgkin's lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 479, doi. 10.1177/10781552221105572
- By:
- Publication type:
- Article
Acute lymphocytic leukemia in a patient with long-term carbamazepine exposure: Acute lymphoblastic leukemia that develops in a patient who has been using carbamazepine for a long time.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 477, doi. 10.1177/10781552221105856
- By:
- Publication type:
- Article
Onco-pharmacist led evaluation of knowledge, attitude & practice (KAP) of safe handling cytotoxic drugs among health care professional's (HCP's) in tertiary care hospital: A hospital based interventional Study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 263, doi. 10.1177/10781552211066957
- By:
- Publication type:
- Article
Use of long-term corticosteroids in patients treated with CAR T-cell therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 473, doi. 10.1177/10781552221104816
- By:
- Publication type:
- Article
Life-threatening altered mental status secondary to memantine in an adolescent undergoing cranial radiotherapy for medulloblastoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 469, doi. 10.1177/10781552221102883
- By:
- Publication type:
- Article
Life threatening hepatotoxicity induced by Nilotinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 465, doi. 10.1177/10781552221102588
- By:
- Publication type:
- Article
Health-related quality of life among cervical cancer patients at Kenyatta National Hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 393, doi. 10.1177/10781552211073886
- By:
- Publication type:
- Article
Community Pharmacists' Knowledge on Cancer and Screening Methods.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 386, doi. 10.1177/10781552211073822
- By:
- Publication type:
- Article
Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 375, doi. 10.1177/10781552211073797
- By:
- Publication type:
- Article
Impact of the COVID-19 pandemic on new starts to oral oncology medications in the US.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 370, doi. 10.1177/10781552211073778
- By:
- Publication type:
- Article
Interpersonal communication-, education- and counselling-based interventions to support adherence to oral anticancer therapy: a systematic review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 358, doi. 10.1177/10781552211073576
- By:
- Publication type:
- Article
Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance?
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 348, doi. 10.1177/10781552211073469
- By:
- Publication type:
- Article
Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 122 centers.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 338, doi. 10.1177/10781552211072877
- By:
- Publication type:
- Article
Daratumumab infusion reaction rates pre- and post-addition of montelukast to pre-medications.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 333, doi. 10.1177/10781552211072876
- By:
- Publication type:
- Article
Clinical and Economic Impact of Pharmacists' Intervention on Care of Pediatric Hematology and Oncology Patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 319, doi. 10.1177/10781552211068139
- By:
- Publication type:
- Article
Incidence and risk factors associated with development of oxalipatin-induced acute peripheral neuropathy in colorectal cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 311, doi. 10.1177/10781552211068138
- By:
- Publication type:
- Article
Assessment of adverse events among cervical cancer patients at Kenyatta National Hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 326, doi. 10.1177/10781552211068133
- By:
- Publication type:
- Article
Daratumumab Monotherapy for Heavily Pre-treated and Refractory Myeloma: Results from a UK Multicentre Real World Cohort.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 299, doi. 10.1177/10781552211067780
- By:
- Publication type:
- Article
Evaluation of early de-escalation of empiric antimicrobial therapy in acute leukemia patients with febrile neutropenia at a large academic medical center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 305, doi. 10.1177/10781552211067776
- By:
- Publication type:
- Article
Analysis of immune-mediated reactions in patients with non-small cell lung cancer treated with nivolumab and its association with effectiveness.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 290, doi. 10.1177/10781552211067429
- By:
- Publication type:
- Article
The impact of medication reconciliation and review in patients using oral chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 270, doi. 10.1177/10781552211066959
- By:
- Publication type:
- Article
The experience of cancer patients during the COVID-19 pandemic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 283, doi. 10.1177/10781552211066891
- By:
- Publication type:
- Article
A pilot study about methods to reduce prescription errors in a chemotherapy day unit – Aspects to consider in pharmacist verification process.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 2, p. 276, doi. 10.1177/10781552211066500
- By:
- Publication type:
- Article